Q: How should Abirakast 250mg Tablet be administered?
A: Abirakast 250mg Tablet is taken orally, typically as directed by a healthcare provider specializing in oncology. It is important to follow the prescribed dosage and administration schedule to achieve optimal therapeutic results.
Q: What are the storage conditions required for Abirakast 250mg Tablet?
A: The tablets should be stored below 30C in a dry place, away from light and moisture, as improper storage may affect their quality and efficacy.
Q: When is Abirakast 250mg Tablet indicated for use in patients?
A: Abirakast 250mg Tablet is indicated for adult men diagnosed with advanced prostate cancer, particularly when traditional therapies are no longer effective.
Q: Where can Abirakast 250mg Tablet be sourced or procured?
A: Abirakast 250mg Tablet is available through authorized exporters, suppliers, traders, and wholesalers in India, strictly on a prescription-only basis for international and domestic markets.
Q: What is the benefit of Abirakast's CYP17 inhibition in prostate cancer therapy?
A: By inhibiting the CYP17 enzyme, Abirakast reduces androgen production, which plays a significant role in the progression of advanced prostate cancer, thereby supporting improved patient outcomes as part of comprehensive cancer management.
Q: How can I obtain a quotation?
A: Please share the required quantity, destination country, and consignee details. We will provide our best quotation along with delivery timelines and shipping options.